These rankings are based on data from April 2025
Company
GEn1E Lifesciences Inc.
Years in business
- 7
Number of employees
- 11-50 employees
Country
- United States
GEn1E Lifesciences employs a machine learning-driven approach to accelerate the development of first-in-class therapies for inflammatory diseases, utilizing unique allosteric binding mechanisms to improve specificity and reduce side effects.
API Availability
- No
Position of GEn1E Lifesciences on sub rankings
April 2025
Drug discovery & development
12
out of 18
Company
GEn1E Lifesciences Inc.
Years in business
- 7
Number of employees
- 11-50 employees
Country
- United States
Insights
Norway’s AI builders: Key Insights from the AI Report Norway 2025
Norway’s AI sector is growing fast, but who is actually building the technology that will shape the future? The newly released AI Report Norway 2025 offers the first data-driven overview of the companies developing new AI-powered products and solutions in the country.
What kind of AI expert are you?
Understanding the 4 layers of the AI expert iceberg